{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-047806","form_type":"8-K","ticker":"XWEL","cik":"0001410428","company_name":"XWELL, Inc.","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.299132+00:00","generated_at":"2026-06-03T22:10:40.821066+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"XWELL reports FY2023 revenue drop to $30.1M, net loss $28.0M; restates Q3 2023 results","bullets":["FY2023 total revenue $30.1M (down 46% from $55.9M in 2022); operating loss $28.2M, net loss $28.0M.","Non-cash impairment charges of $8.9M; restated Q3 2023 to correct $1.6M understatement of Treat segment impairment.","XpresSpa revenue grew 39% YoY to $19.5M; plans for Penn Station location and Naples Wax Center expansion to ~10 locations by early 2025.","CDC biosurveillance program expanded to $36.7M funding; new collection sites at MIA and ORD.","Cash and marketable securities totaled $23.0M at Dec 31, 2023; no long-term debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-047806","json":"https://secwatch.observer/filing/0001104659-24-047806.json","markdown":"https://secwatch.observer/filing/0001104659-24-047806.md","text":"https://secwatch.observer/filing/0001104659-24-047806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924047806/0001104659-24-047806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924047806/tm2411854d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:10:40.821066+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96cebaffa3a6d36e9b7eaa6a642c9bbb50e56cee","claim":"XWELL, Inc. reported financial results for fiscal year ended December 31, 2023.","evidence_excerpt":"On April 16, 2024, XWELL, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year ended December 31, 2023, and provided a corporate update.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924047806/0001104659-24-047806-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}